Ramsay Health Care Ltd (ASX: RHC) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Ramsay Health Care Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $10.84 billion
P/E Ratio 52.66
Dividend Yield 1.35%
Shares Outstanding 229.75 million
Earnings per share 0.911
Dividend per share 0.80
Year To Date Return -8.04%
Earnings Yield 1.90%
Franking 100%
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Ramsay Health Care Ltd (ASX: RHC)
    Latest News

    Businessman smiles with arms outstretched after receiving good news.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was another strong showing from the share market today.

    Read more »

    A young woman holding her phone smiles broadly and looks excited, after receiving good news.
    Share Gainers

    Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

    These shares are having a strong session. But why?

    Read more »

    A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
    Mergers & Acquisitions

    Wesfarmers shares baulk on fresh acquisition gossip

    A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

    Read more »

    a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
    Share Market News

    5 things to watch on the ASX 200 on Friday

    It looks set to be a tough finish to the week for Aussie investors.

    Read more »

    A woman is excited as she reads the latest rumour on her phone.
    Broker Notes

    These ASX 200 shares could rise 20% to 40%

    Analysts think these shares could deliver big returns for investors.

    Read more »

    A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
    Share Market News

    5 things to watch on the ASX 200 on Monday

    The Australian share market looks to have run out of steam on Monday.

    Read more »

    ASX shares Business man marking buy on board and underlining it
    Broker Notes

    Brokers name 3 ASX shares to buy now

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    A woman leaps into the air with loads of energy, in a lush green field.
    Share Market News

    Here are the top 10 ASX 200 shares today

    The ASX 200 had a Thursday to remember today.

    Read more »

    A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
    Share Gainers

    Why Harvey Norman, Macquarie Technology, Ramsay Health Care, and Star are rising

    These ASX shares are having a strong day. But why?

    Read more »

    Health professional working on his laptop.
    Healthcare Shares

    Ramsay Health Care share price falls on profit crunch and dividend cut

    This private hospital operator continues to battle with higher costs.

    Read more »

    Business woman watching stocks and trends while thinking
    Share Market News

    5 things to watch on the ASX 200 on Thursday

    Will investors be leaping for joy on 29 February?

    Read more »

    three Lendlease builders on construction site
    Cheap Shares

    'Attractive recovery play': 2 ASX 200 shares ready to rock after a SHOCKING 2023

    These stocks are cheap now but are set to have a massive 2024 with increased earnings.

    Read more »

    Frequently Asked Questions

    Yes, Ramsay Health Care has historically paid two fully franked dividends a year.

    Ramsay Health Care generally pays its shareholder dividends in March and September. 

    Ramsay Health Care Ltd listed on the ASX on 24 September 1997.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    11 Mar 2024 $0.4000 100.00% Interim 05 Apr 2024
    06 Sep 2023 $0.2500 100.00% Final 29 Sep 2023
    06 Mar 2023 $0.5000 100.00% Interim 30 Mar 2023
    05 Sep 2022 $0.4850 100.00% Final 29 Sep 2022
    07 Mar 2022 $0.4850 100.00% Interim 31 Mar 2022
    06 Sep 2021 $1.0300 100.00% Final 30 Sep 2021
    08 Mar 2021 $0.4850 100.00% Interim 31 Mar 2021
    05 Mar 2020 $0.6250 100.00% Interim 27 Mar 2020
    05 Sep 2019 $0.9150 100.00% Final 30 Sep 2019
    06 Mar 2019 $0.6000 100.00% Interim 29 Mar 2019
    05 Sep 2018 $0.8650 100.00% Final 28 Sep 2018
    06 Mar 2018 $0.5750 100.00% Interim 29 Mar 2018
    05 Sep 2017 $0.0000 100.00% Final 28 Sep 2017
    07 Mar 2017 $0.5300 100.00% Interim 29 Mar 2017
    06 Sep 2016 $0.7200 100.00% Final 29 Sep 2016
    08 Mar 2016 $0.4700 100.00% Interim 30 Mar 2016
    08 Sep 2014 $0.5100 100.00% Final 24 Sep 2014
    04 Mar 2014 $0.3400 100.00% Interim 26 Mar 2014
    03 Sep 2013 $0.4150 100.00% Final 25 Sep 2013
    04 Mar 2013 $0.2900 100.00% Interim 27 Mar 2013
    05 Mar 2012 $0.2550 100.00% Interim 28 Mar 2012
    02 Sep 2011 $0.2950 100.00% Final 26 Sep 2011
    08 Mar 2011 $0.2250 100.00% Interim 28 Mar 2011
    31 Aug 2010 $0.2500 100.00% Final 27 Sep 2010
    16 Mar 2010 $0.1850 100.00% Interim 09 Apr 2010
    21 Sep 2009 $0.2150 100.00% Final 09 Oct 2009
    20 Mar 2009 $0.1650 100.00% Interim 08 Apr 2009
    25 Sep 2008 $0.1750 100.00% Final 15 Oct 2008
    26 Sep 2007 $0.1600 100.00% Final 12 Oct 2007
    27 Mar 2006 $0.1050 100.00% Interim 12 Apr 2006
    26 Sep 2005 $0.1150 100.00% Final 14 Oct 2005
    16 Apr 2004 $0.0750 100.00% Interim 30 Apr 2004

    RHC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Ramsay Health Care Ltd

    Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

    As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.

    It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.

    The vast majority of the company's revenue is generated from its Australian and European operations.

    RHC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 May 2024 $47.98 $-1.54 -3.11% 540,975 $49.45 $49.63 $47.83
    27 May 2024 $49.52 $0.85 1.75% 429,727 $48.95 $50.35 $48.85
    24 May 2024 $48.67 $-0.76 -1.54% 324,632 $48.84 $49.09 $48.62
    23 May 2024 $49.43 $0.57 1.17% 598,628 $48.56 $49.43 $48.43
    22 May 2024 $48.86 $-0.10 -0.20% 398,180 $48.93 $48.96 $48.28
    21 May 2024 $48.96 $-0.80 -1.61% 560,109 $49.51 $49.68 $48.72
    20 May 2024 $49.76 $-0.23 -0.46% 288,970 $49.93 $50.22 $49.55
    17 May 2024 $49.99 $-0.96 -1.88% 547,043 $50.57 $50.59 $49.80
    16 May 2024 $50.95 $0.16 0.32% 499,897 $51.51 $51.65 $50.87
    15 May 2024 $50.79 $-0.51 -0.99% 221,003 $51.40 $51.48 $50.76
    14 May 2024 $51.30 $0.51 1.00% 397,918 $50.74 $51.80 $50.61
    13 May 2024 $50.79 $0.68 1.36% 304,961 $50.24 $50.82 $50.08
    10 May 2024 $50.11 $-0.20 -0.40% 394,074 $50.20 $50.40 $49.83
    09 May 2024 $50.31 $-0.89 -1.74% 403,871 $51.00 $51.00 $50.12
    08 May 2024 $51.20 $-0.40 -0.78% 387,145 $51.58 $51.75 $50.91
    07 May 2024 $51.60 $0.50 0.98% 317,318 $51.40 $51.81 $51.04
    06 May 2024 $51.10 $-0.12 -0.23% 359,334 $51.15 $51.69 $51.03
    03 May 2024 $51.22 $0.24 0.47% 325,915 $51.13 $51.52 $50.90
    02 May 2024 $50.98 $-0.10 -0.20% 469,629 $51.07 $51.57 $50.93
    01 May 2024 $51.08 $-1.17 -2.24% 355,148 $51.75 $51.87 $51.08
    30 Apr 2024 $52.25 $-0.25 -0.48% 298,058 $51.80 $52.43 $51.80

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    22 Dec 2023 Claudia Dyckerhoff Buy 2,500 $128,275
    On-market trade.
    15 Dec 2023 Craig McNally Issued 64,625 $3,261,623
    Issue of securities. 172,129 Performance Rights
    20 Nov 2023 Karen Penrose Buy 195 $9,935
    On-market trade.
    16 Nov 2023 David Thodey Buy 4,000 $210,509
    On-market trade.
    15 Nov 2023 Karen Penrose Buy 665 $34,972
    On-market trade.
    14 Nov 2023 Craig McNally Issued 7,674 $391,084
    Issue of securities. VWAP
    31 Aug 2023 Craig McNally Expiry 55,563 $2,858,716
    As advised by the company. 107,504 Performance Rights, lapsed

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Ingle Thodey Non-Executive DirectorNon-Executive Chairman Nov 2017
    Mr Thodey is a business leader focused on innovation, technology, digital transformation and telecommunications, with more than 40 years of experience. In addition to being a Non Executive Director and Lead Independent Director of Ramsay, Mr Thodey is currently Chair of Xero Limited. He is also a member of the Finance Committee at the University of Sydney, Chair of the Great Barrier Reef Foundation and co-chair of the Climate Leaders Coalition. Mr Thodey was previously CEO of Telstra Chair of CSIRO and, prior to that, he was CEO of IBM Australia and New Zealand. Mr Thodey is active in public policy and has led an Independent Review of the Australian Public Service in 2019, chaired a Panel appointed by the NSW Government to lead an independent review of Federal Financial Relations between the Commonwealth and the States in 2020, and led a user audit of the myGov government services digital portal in 2023. From March to December 2020, Mr Thodey was also Deputy Chair of the Federal Government's National COVID-19 Coordination Commission NCC Advisory Board. He is Chair of Governance Committee & Member of People Committee.
    Ms Catriona Alison Deans Non-Executive Director Nov 2018
    Ms Alison Deans has 25 years' experience building technology enabled businesses involved in media, ecommerce, financial services and health, and across leadership roles as an executive, a director and in venture capital. Ms Deans joined the Board of Ramsay Health Care in November 2018. She is also Chair of Cochlear Limited and a Non Executive Director of Calix Limited and Deputy Pty Ltd. She is also a Venture Partner of Main Sequence Ventures. In her executive career, Ms Deans was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited, a publicly listed portfolio of digital businesses, CEO of Hoyts Cinemas and recently CEO of Netus Pty Ltd a technology investment company acquired by Fairfax. She is Chair of People Committee and Member of Governance Committee.
    Mr Michael Stanley Siddle Non-Executive Director May 1975
    Mr Michael Siddle was appointed as Chairman of the Company on 27 May 2014, having formerly been Deputy Chairman for 17 years and a founding Director. He has built up knowledge of the business and the private hospital industry after starting with the Company in 1968. Mr Siddle has extensive experience in the management of private hospitals and has been involved in Ramsay Health Care's successful through developments, mergers and acquisitions. Mr Siddle is also a Trustee and director of the Paul Ramsay Foundation. During the last three years, Mr Siddle has not served as a director of any listed companies other than Ramsay Health Care Limited. He is Member of People and Governance Committee.
    Mr Craig Ralph McNally Chief Executive OfficerManaging Director Jul 2017
    Mr Craig McNally was appointed Managing Director and Chief Executive Officer on 3 July 2017, after serving seven years as Chief Operating Officer and 22 years in various roles including Head of Global Strategy and European Operations. Mr McNally is also the Chairman of Ramsay Sante. Mr McNally joined Ramsay in 1988 and is one of the Company's serving executives. During his tenure, he has worked across operational, strategic and financial roles. For the last two decades, Mr McNally has been responsible for the development and implementation of Ramsay's growth including brownfield expansions, international market assessments, mergers and acquisitions and business strategies. He has been at the forefront of all the major acquisitions and deals. His ability to assess the opportunities and risks associated with new business ventures and to evaluate their 'strategic fit', as well as his judgement and insight, has ensured the Company's growth both domestically and internationally. Mr McNally has been a key leader in the development of The Ramsay Way culture and in developing leadership within the global organisation.
    Ms Helen Kurincic Non-Executive Director Mar 2024
    Ms Kurincic brings executive and board-level experience across the healthcare industry most recently as the Chair of Australian & New Zealand imaging company, Integral Diagnostics (December 2014 - November 2023), and a Non-Executive Director of Australian health insurer, HBF Health (February 2016 - February 2024). Helen has previously held other Executive and Non-Executive healthcare sector roles. Non-Executive Director roles include Estia Health, Victorian Clinical Genetics Service, Sirtex, DCA Group, AMP Capital Investors Domain Principal Group, Melbourne Health and Orygen Youth Mental Health Research Centre. Previous Executive roles include Chief Operating Officer of GenesisCare from its earliest inception in Australia and CEO Heart Care Victoria and CEO of Benetas. Helen has previously also been involved in healthcare government policy reform, including appointments by Health Ministers as Chair of the Professional Programs and Services Committee for the Fourth Community Pharmacy Agreement and Member of the Ministers Implementation Taskforce and Ministers Reference Group for the Long Term Reform of Aged Care. Helen started her healthcare career from the ground up, originally as a nurse at the Royal Melbourne Hospital specialising in intensive care. Helen is currently the Chair of McMillan Shakespeare and a Non-Executive Director of the Carlton Football Club.
    Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
    Ms Karen Penrose has had an executive career in leadership and CFO roles, in financial services. She is in financial management, customer outcomes and operating in a changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed company CFO. Ms Penrose has been a full-time director since 2014 and is an experienced committee chair of audit and risk. In addition to being a Non-Executive Director of Ramsay, Ms Penrose also serves as a Director of Ramsay Generale de Sante and as a member of their Audit Committee, and as a Director of Bank of Queensland, Cochlear and Estia Health. She is a member of Chief Executive Women and on the Board of Marshall Investments Pty Limited and Rugby Australia Limited. She is Member of Risk Management Committee.
    Mr Steven Andrew Sargent Non-Executive Director Nov 2021
    Mr Steven Sargent's executive career included 22 years at General Electric, where he gained multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe and Asia Pacific. Mr Sargent is currently a Non-Executive Director of Origin Energy Limited and Chair of infection prevention company Nanosonics Limited. His unlisted board activities include Chairman of The Origin Energy Foundation Limited, Origin's philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation. He is Chair of Risk Management Committee.
    Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director Oct 2018
    Dr Dyckerhoff joined the Ramsay Health Care Board in October 2018, bringing in market growth strategies, business development and operational performance improvement in hospitals. Dr Dyckerhoff has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and transferred to the USA focusing on supporting health care companies, including pharmaceutical & medical device companies, payor, provider and health systems in Europe and the USA. In 2006, Dr Dyckerhoff transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She also led McKinsey's Asia-wide Health Systems and Services Sector. In 2016, when she was nominated to the Board of Hoffmann-La Roche, she stepped down from her role as Senior Partner and took on an external advisor role. Dr Dyckerhoff also supports start-ups in the health care area; she joined the board of the Health Tech company HUMA in April 2021 and the board of QuEST Global in November 2020. She is Member of Risk Management Committee.
    Mr James Malcolm McMurdo Non-Executive Director Sep 2019
    Mr McMurdo has more than 30 years' finance and banking experience. He has a background in corporate advisory across mergers and acquisitions, strategic advisory and financing with experience across multiple industries including the healthcare sector. He has held senior operating management roles and worked in both the Asia Pacific and European regions. Mr McMurdo is one of the Founding Partners of Privatus Capital Partners, an advisory and merchant banking business. Prior to establishing Privatus, he held senior management roles at Deutsche Bank and was based in Hong Kong. In the time he was at Deutsche Bank, Mr McMurdo was Global Co-Head of Corporate Finance, Head of Corporate and Investment Bank for Asia Pacific and CEO for Australia and New Zealand. He sat on the firm's Global Executive Committee for the Corporate and Investment Bank for four years. Prior to this, Mr McMurdo was a Partner at Goldman Sachs, where he held senior positions in the Investment Banking Division in Australia and Europe.
    Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
    Martyn Roberts Chief Financial Officer
    Henrietta Rowe Company SecretaryGroup General Counsel

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 50,937,056 22.23%
    J P Morgan Nominees Australia Pty Limited 30,982,831 13.52%
    Netwealth Investments Limited <Wrap Services A/C> 23,759,975 10.37%
    Paul Ramsay Holdings Pty Limited 20,713,455 9.04%
    Citicorp Nominees Pty Limited 17,563,256 7.66%
    National Nominees Limited 6,130,398 2.67%
    BNP Paribas Noms Pty Ltd <DRP> 3,771,448 1.65%
    Woolwich Investments Pty Ltd <The Siddle Family Trust> 3,750,000 1.64%
    Custodial Services Limited <Beneficiaries Holding A/C> 2,948,847 1.29%
    Argo Investments Limited 2,023,131 0.88%
    Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 1,604,263 0.70%
    Washington H Soul Pattinson And Company Limited 1,304,499 0.57%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 1,257,589 0.55%
    Australian Foundation Investment Company Limited 1,226,000 0.54%
    Bnp Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 1,208,579 0.53%
    Mutual Trust Pty Ltd 935,998 0.41%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 883,942 0.39%
    Certane Ct Pty Ltd <Ramsay Unallocated Ac> 880,466 0.38%
    Hsbc Custody Nominees (Australia) Limited II 682,900 0.30%
    UBS Nominees Pty Ltd 661,134 0.29%